Australia markets closed

China Biologic Products Holdings, Inc. (CBPO)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
118.37+0.37 (+0.31%)
As of 9:33AM EDT. Market open.
Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
524,368
524,368
503,745
466,878
370,407
Cost of revenue
179,942
179,942
174,667
146,787
125,517
Gross profit
344,426
344,426
329,078
320,090
244,890
Operating expenses
Research development
8,583
8,583
11,735
9,524
6,504
Selling general and administrative
140,469
140,469
153,696
164,393
102,528
Total operating expenses
149,052
149,052
165,430
173,918
109,031
Operating income or loss
195,374
195,374
163,648
146,173
135,859
Interest expense
324.061
324.061
557.597
338.136
583.432
Total other income/expenses net
7,338
7,338
7,081
6,462
3,509
Income before tax
214,058
214,058
191,494
166,003
146,408
Income tax expense
35,736
35,736
28,099
18,036
64,172
Income from continuing operations
178,321
178,321
163,395
147,967
82,236
Net income
152,285
152,285
138,808
128,056
67,943
Net income available to common shareholders
152,285
152,285
137,117
124,984
65,754
Basic EPS
-
-
3.55
3.54
2.40
Diluted EPS
-
-
3.53
3.53
2.38
Basic average shares
-
-
38,658
35,304
27,362
Diluted average shares
-
-
38,898
35,433
27,606
EBITDA
-
241,581
218,292
189,567
159,900